Early serum creatinine changes and outcomes in patients admitted for acute heart failure: the cardio-renal syndrome revisited

European Heart Journal: Acute Cardiovascular Care

Volumn 6, Issue 5, 2017, Pages 430-440

  Núñez, Julio ^a   Garcia, Sergio ^a   Núñez, Eduardo ^a   Bonanad, Clara ^a   Bodí, Vicent ^a   Miñana, Gema ^a   Santas, Enrique ^a   Escribano, David ^a   Bayes Genis, Antonio ^b   Pascual Figal, Domingo ^c   Chorro, Francisco J ^a   Sanchis, Juan ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c UNIVERSITY OF MURCIA   (Spain)

Author keywords

absolute creatinine changes; acute decompensated heart failure; mortality; renal failure; worsening renal function

Indexed keywords

CREATININE; BIOLOGICAL MARKER;

ACUTE HEART FAILURE; AGED; ARTICLE; CARDIORENAL SYNDROME; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GENDER; HOSPITAL ADMISSION; HOSPITAL MORTALITY; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC BLOOD PRESSURE; ACUTE DISEASE; BLOOD; CAUSE OF DEATH; COMPLICATION; FOLLOW UP; HEART FAILURE; HOSPITAL PATIENT; MORTALITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SPAIN; SURVIVAL RATE; TIME FACTOR; TRENDS;

ACUTE DISEASE; AGED; BIOMARKERS; CARDIO-RENAL SYNDROME; CAUSE OF DEATH; CREATININE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; INPATIENTS; MALE; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SPAIN; SURVIVAL RATE; TIME FACTORS;

EID: 85050579838     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872614540094     Document Type: Article

References (27)

1. Butler J, Chirovsky D, Phatak H. Renal function, health outcomes, and resource utilization in acute heart failure: a systematic review. Circ Heart Fail 2010; 3: 726–745.
2. Maeder MT, Rickli H, Pfisterer ME, ; TIME-CHF Investigators. Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy. Am Heart J 2012; 163: 407–414.
3. Damman K, Navis G, Voors AA. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail 2007; 13: 599–608.
4. Testani JM, Damman K., Venous congestion and renal function in heart failure … it’s complicated. Eur J Heart Fail 2013; 15: 599–601.
5. Ljungman S, Laragh JH, Cody RJ., Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs 1990; 39 Suppl 4: 10–21; discussion 22–24.
6. McMurray JJ, Adamopoulos S, Anker SD, ; ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787–1847.
7. Damman K, Ng Kam Chuen MJ, MacFadyen RJ. Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function. J Am Coll Cardiol 2011; 57: 2233–2241.
8. Mullens W, Abrahams Z, Francis GS. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009; 53: 589–596.
9. Ross EA. Congestive renal failure: the pathophysiology and treatment of renal venous hypertension. J Card Fail 2012; 18: 930–938.
10. Paterna S, Parrinello G, Cannizzaro S. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. Am J Cardiol 2009; 103: 93–102.
11. Mullens W, Abrahams Z, Francis GS. Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. J Card Fail 2008; 14: 508–514.
12. Mullens W, Abrahams Z, Skouri HN. Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 2008; 51: 300–306.
13. Metra M, Davison B, Bettari L. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail 2012; 5: 54–62.
14. Testani JM, Chen J, McCauley BD. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 2010; 122: 265–272.
15. Greene SJ, Gheorghiade M, Vaduganathan M, ; EVEREST Trial investigators. Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Eur J Heart Fail 2013; 112: 1763–1769.
16. van der Meer P, Postmus D, Ponikowski P. The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. J Am Coll Cardiol 2013; 61: 1973–1981.
17. Roy AK, Mc Gorrian C, Treacy C. A comparison of traditional and novel definitions (RIFLE, AKIN, and KDIGO) of acute kidney injury for the prediction of outcomes in acute decompensated heart failure. Cardiorenal Med 2013; 3: 26–37.
18. Sheerin NJ, Newton PJ, Macdonald PS. Worsening renal function in heart failure: The need for a consensus definition. Int J Cardiol. Epub ahead of print 21 April 2014. DOI: 10.1016/j.ijcard.2014.04.162.
19. Dickstein K, Cohen-Solal A, Filippatos G, ; ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29: 2388–2442.
20. Levey AS, Coresh J, Greene T. Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247–254.
21. Royston P, Parmar MK., Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 2002; 21: 2175–2197.
22. Sauerbrei W, Royston P, Binder H., Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med 2007; 26: 5512–5528.
23. Damman K, Valente MA, Voors AA. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 2014; 35: 455–469.
24. Teerlink JR, Metra M, Felker GM. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet 2009; 373: 1429–1439.
25. Teerlink JR, Cotter G, Davison BA, ; RELAX in in Acute Heart Failure (RELAX-AHF) Investigators. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 2013; 381: 29–39.
26. Metra M, Cotter G, Davison BA, ; RELAX-AHF Investigators. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J Am Coll Cardiol 2013; 61: 196–206.
27. Taub PR, Borden KC, Fard A. Role of biomarkers in the diagnosis and prognosis of acute kidney injury in patients with cardiorenal syndrome. Expert Rev Cardiovasc Ther 2012; 10: 657–667.